Sujay Kango
Vorstandsvorsitzender bei Tmunity Therapeutics, Inc.
Vermögen: - $ am 31.01.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Justin File | M | 53 | 1 Jahre | |
| Tom Glocer | M | 63 | 17 Jahre | |
| Rebecca Roberts | F | 71 | 6 Jahre | |
| Carl June | M | 70 |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | - |
| Melody Meyer | F | 66 | 7 Jahre | |
| Dalton Smart | M | 58 | 15 Jahre | |
| Chirfi Guindo | M | 58 | 13 Jahre | |
| Steven Wood | M | 41 | 1 Jahre | |
| James Flynn | M | 43 | 1 Jahre | |
| Caroline Ruiz | F | - | 2 Jahre | |
| Jason Sausser | M | - | 2 Jahre | |
| Steven Graziano | M | - | 18 Jahre | |
| Taheer Mehboob Datoo | M | 33 | 1 Jahre | |
| Judith Li | F | 40 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | - |
| Denise Williams | F | - | 15 Jahre | |
| Pamela Eisele | F | - | 15 Jahre | |
| Beth Seidenberg | M | 67 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | - |
| Sanat Chattopadhyay | M | - | 15 Jahre | |
| Anne Frese | F | - | 2 Jahre | |
| Patrick M. Gray | M | 75 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 5 Jahre |
| Jorge Conde | M | 47 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 5 Jahre |
| Sean Parker | M | 44 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 6 Jahre |
| Li Ming | M | - |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| N. Coles | M | 63 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 Jahre |
| Lawrence Bloch | M | 58 | 11 Jahre | |
| Brian Drazba | M | 63 | 6 Jahre | |
| Christine Anna White | M | 72 | 13 Jahre | |
| Fred Hassan | M | 78 | 6 Jahre | |
| Daniel Gold | M | 70 | 13 Jahre | |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 Jahre |
| Wendy Yarno | F | 68 | 9 Jahre | |
| Vito Palombella | M | 61 | 12 Jahre | |
| Julie Gerberding | M | 69 | - | |
| Kenneth Bartizal | M | 72 | 20 Jahre | |
| Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 Jahre |
| Tamar Howson | F | 75 | 4 Jahre | |
| Gwen A. Fyfe | M | 72 | 4 Jahre | |
| Craig Thompson | M | 71 | 10 Jahre | |
| Carole A. Sable | M | 62 | 16 Jahre | |
| Ismail Kola | M | 67 | 4 Jahre | |
| Jaren Madden | F | - | 7 Jahre | |
| Jean-Marie Canan | M | 68 | 5 Jahre | |
| Robert Iannone | M | 57 | 6 Jahre | |
| Samuel Agresta | M | 51 | 5 Jahre | |
| Thomas Robert Cech | M | 76 | - | |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 Jahre |
| Helen Torley | M | 61 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
| Carlos Eduardo Represas de Almeida | M | 78 | - | |
| Leslie Brun | M | 72 | 13 Jahre | |
| Caroline Dorsa | F | 64 | 22 Jahre | |
| Richard Henriques | M | 68 | 27 Jahre | |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 Jahre |
| Kevan E. Clemens | M | 80 | 7 Jahre | |
| Christopher M. Lindblom | M | 52 | - | |
| Natarajan Sethuraman | M | 62 | 10 Jahre | |
| Cheryl Cohen | F | 58 | 2 Jahre | |
| Steven Goldstone | M | 78 | 6 Jahre | |
| Harry R. Jacobson | M | 76 | 3 Jahre | |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 Jahre |
| Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 Jahre |
| Ofir Moreno | M | - | 12 Jahre | |
| William N. Kelley | M | 84 | - | |
| David Anstice | M | 75 | 5 Jahre | |
| Eric S. Lander | M | 67 | 10 Jahre | |
| Zane Yang | M | - | 3 Jahre | |
| Corey Padovano | M | - | 4 Jahre | |
| Ernesto Aycardi | M | 61 | 11 Jahre | |
| Francesco Maria Lavino | M | 51 | 2 Jahre | |
| Christopher Morabito | M | 54 | 4 Jahre | |
| Lisa Escudero | F | 62 | 18 Jahre | |
| Christine Cioffe | F | - | 20 Jahre | |
| Louisa Shaw-Marotto | F | 56 | 3 Jahre | |
| Craig Granowitz | M | 60 | 12 Jahre | |
| Sheela Mohan-Peterson | F | 61 | 5 Jahre | |
| Jeffrey Chodakewitz | M | 68 | 4 Jahre | |
| Rita Karachun | F | 61 | 14 Jahre | |
| Barry Goldstein | M | - | 5 Jahre | |
| Steven Hubrig Koehler | M | 73 | 2 Jahre | |
| Karen Ling | F | 60 | 6 Jahre | |
| Lee Ausburn | F | - | 26 Jahre | |
| Bradley Sheares | M | 67 | 19 Jahre | |
| Richard Murray | M | 65 | 5 Jahre | |
| Martin Duvall | M | 62 | 1 Jahre | |
| Christina Morrison | F | 57 | 4 Jahre | |
| C. Nicholson | M | 69 | 2 Jahre | |
| Lars Kåre Viksmoen | M | 75 | 14 Jahre | |
| Deborah Law | M | - | 4 Jahre | |
| David A. Esposito | M | 55 | 13 Jahre | |
| James F. Fuqua | M | - | 31 Jahre | |
| Kathleen Metters | M | 66 | 13 Jahre | |
| Anastasia Daifotis | M | - | - | |
| Gregory L. Tewalt | M | - | 18 Jahre | |
| Patricia Maxson | M | 65 | - | |
| Wei Tang | M | - | 15 Jahre | |
| Andrew Plump | M | 58 | - | |
| Terrie Curran | F | 55 | 4 Jahre | |
| Jim Robinson | M | - | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sujay Kango
- Persönliches Netzwerk
